UNDERWRITER COMMON STOCK PURCHASE WARRANT MICROBOT MEDICAL INC.Microbot Medical Inc. • February 8th, 2019 • Biological products, (no disgnostic substances) • New York
THIS UNDERWRITER COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the six-month anniversary of the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on ______________1 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Microbot Medical Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
PRE-FUNDED COMMON STOCK PURCHASE WARRANT Microbot Medical Inc.Microbot Medical Inc. • February 8th, 2019 • Biological products, (no disgnostic substances) • New York
THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”), to subscribe for and purchase from Microbot Medical Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
MICROBOT MEDICAL INC. UNDERWRITING AGREEMENTUnderwriting Agreement • February 8th, 2019 • Microbot Medical Inc. • Biological products, (no disgnostic substances) • New York
Microbot Medical Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein (the “Agreement”), to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom H.C. Wainwright & Co., LLC, is acting as representative (the “Representative”), an aggregate of (a) [●] shares of common stock (the “Common Stock”), par value $0.01 per share, of the Company (the “Firm Shares”) and (b) pre-funded warrants (the “Pre-Funded Warrants” and, collectively with the Firm Shares, the “Firm Securities”) to purchase up to an aggregate of [●] shares of Common Stock at an exercise price of $0.01 per share (the “Pre-Funded Warrant Shares”) The Firm Shares and the Pre-Funded Warrants are referred to herein as the “Firm Securities.” The respective amounts of the Firm Securities to be purchased by each of the several Underwriters are set forth opposite their names on Schedule I hereto. In addition, the Compan
